News
![myfembree](https://pharmaphorum.com/wp-content/uploads/2021/05/myfembree.jpg)
FDA clears Myovant's relugolix for uterine fibroids, setting...
Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first once-daily oral drug in the US to treat heavy menstrual bleeding associated with ut